+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
Oral Antiepileptic Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Antiepileptic Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Botulinum Toxin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Botulinum Toxin Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Pediatric Neuroblastoma Treatment Market Report 2026 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Dermatological Drugs Market Report 2024-2034 - Product Thumbnail Image

Dermatological Drugs Market Report 2024-2034

  • Report
  • February 2024
  • 280 Pages
  • Global
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Loading Indicator